The University of Chicago Header Logo

Phase I trial and pharmacokinetics of aziridinylbenzoquinone (NSC 182986) in humans.

Phase I trial and pharmacokinetics of aziridinylbenzoquinone (NSC 182986) in humans. Cancer Res. 1982 Apr; 42(4):1582-6.

View in: PubMed